Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients

Influenza and other Respiratory Viruses

Volumn 6, Issue 6, 2012, Pages

  Tran, Dat ^a,b   Science, Michelle ^a   Dix, David ^c   Portwine, Carol ^d   Zelcer, Shayna ^e   Johnston, Donna L ^f   Yanofsky, Rochelle ^g   Gassas, Adam ^a,b   Ethier, Marie Chantal ^a   Sung, Lillian ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c BC CHILDREN S HOSPITAL   (Canada)

^d HAMILTON HEALTH SCIENCES   (Canada)

^e London Health Sciences   (Canada)

^f CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^g CANCERCARE MANITOBA   (Canada)

Author keywords

Cancer; Child; Pandemic H1N1 influenza; Stem cell transplant

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; OSELTAMIVIR;

2009 H1N1 INFLUENZA; ARTICLE; CANADA; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEVER; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; NEUTROPENIA; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; TREATMENT DURATION; VIRUS SHEDDING;

ADOLESCENT; ANTIVIRAL AGENTS; CANADA; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; NEOPLASMS; OSELTAMIVIR; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VIRUS SHEDDING;

EID: 84867703477     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00352.x     Document Type: Article

References (44)

1. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-689.
2. World Health Organization. Pandemic (H1N1) 2009 - update 104. Available at: http://www.who.int/csr/don/2010_06_11/en/index.html (Accessed 21 June 2010 [cited 2010 21 June]: Available from: http://www.who.int/csr/don/2010_06_11/en/index.html).
3. Maltezou HC, Kafetzis DA, Abisaid D, Mantzouranis EC, Chan KW, Rolston KV. Viral infections in children undergoing hematopoietic stem cell transplant. Pediatr Infect Dis J 2000; 19:307-312.
4. Kempe A, Hall CB, MacDonald NE et al. Influenza in children with cancer. J Pediatr 1989; 115:33-39.
5. Christensen MS, Nielsen LP, Hasle H. Few but severe viral infections in children with cancer: a prospective RT-PCR and PCR-based 12-month study. Pediatr Blood Cancer 2005; 45:945-951.
6. Lujan-Zilbermann J, Benaim E, Tong X, Srivastava DK, Patrick CC, DeVincenzo JP. Respiratory virus infections in pediatric hematopoietic stem cell transplantation. Clin Infect Dis 2001; 33:962-968.
7. Feldman S, Webster RG, Sugg M. Influenza in children and young adults with cancer: 20 cases. Cancer 1977; 39:350-353.
8. Moore DL, Vaudry W, Scheifele DW et al. Surveillance for influenza admissions among children hospitalized in Canadian immunization monitoring program active centers, 2003-2004. Pediatrics 2006; 118:e610-e619.
9. Roberts A, Bitnun A, McGeer A et al. Laboratory-confirmed influenza-associated hospitalizations among children in the metropolitan Toronto and Peel region by active surveillance, 2004-2005. Can Commun Dis Rep 2006; 32:203-207.
10. Quach C, Piche-Walker L, Platt R, Moore D. Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics 2003; 112:e197-e201.
11. Van Kerkhove MD, Vandemaele KA, Shinde V et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011; 8:e1001053.
12. Cost C, Brock E, Adams-Huet B, Siegel JD, Ardura MI. 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. Pediatr Blood Cancer 2011; 56:127-133.
13. Caselli D, Carraro F, Castagnola E et al. Morbidity of pandemic H1N1 influenza in children with cancer. Pediatr Blood Cancer 2010; 55:226-228.
14. Amayiri N, Madanat F. Retrospective analysis of pediatric cancer patients diagnosed with the pandemic H1N1 influenza infection. Pediatr Blood Cancer 2011; 56:86-89.
15. Ozdemir N, Celkan T, Midilli K et al. Novel influenza a (H1N1) infection in a pediatric hematology oncology clinic during the 2009-2010 pandemia. Pediatr Hematol Oncol 2011; 28:288-293.
16. Souza TM, Salluh JI, Bozza FA et al. H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis. PLoS ONE 2010; 5:e14158.
17. Dawood FS, Jain S, Finelli L et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009; 360:2605-2615.
18. Cutler J, Schleihauf E, Hatchette TF et al. Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. CMAJ 2009; 4:159-163.
19. Petrich A, Luinstra K, Chong S, Mahony JB, Smieja M. Performance comparison of commercial molecular assays to detect and identify pandemic influenza A in a sensitivity panel and in clinical specimens (abstract). 26th Clinical Virology Symposium. 2010 April 25-28:S35.
20. Zimmer SM, Crevar CJ, Carter DM, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One 2010; 5:e11601.
21. Helferty M, Vachon J, Tarasuk J, Rodin R, Spika J, Pelletier L. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ 2010; 182:1981-1987.
22. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000; 8:1-27.
23. Litchfield SM. Summary recommendations by the advisory committee on immunization practices (ACIP) for the use of H1N1 influenza vaccine for the 2009-2010 vaccination season. AAOHN J 2009; 57:354.
24. Hernan MA, Lipsitch M. Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials. Clin Infect Dis 2011; 53:277-279.
25. Heinonen S, Silvennoinen H, Lehtinen P et al. Early oseltamivir treatment of influenza in children 1-3years of age: a randomized controlled trial. Clin Infect Dis 2010; 51:887-894.
26. To KK, Hung IF, Li IW et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010; 50:850-859.
27. Hagau N, Slavcovici A, Gonganau DN et al. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 2010; 14:R203.
28. Monsalvo AC, Batalle JP, Lopez MF et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nat Med 2010; 17:195-199.
29. Centers for Disease Control and Prevention. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1071-1074.
30. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.]. 2004; 39:1300-1306.
31. Chemaly RF, Ghosh S, Bodey GP et al. Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine 2006; 85:278-287.
32. Louie JK, Acosta M, Winter K et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009; 302:1896-1902.
33. Morgan OW, Bramley A, Fowlkes A et al. Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease. PLoS ONE 2010; 5:e9694.
34. Louie JK, Acosta M, Samuel MC et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011; 52:301-312.
35. American Academy of Pediatrics Committee on Infectious Diseases. Antiviral therapy and prophylaxis for influenza in children. Pediatrics 2007; 119:852-860.
36. Harper SA, Bradley JS, Englund JA et al. Seasonal influenza in adults and children - diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the infectious diseases society of America. Clin Infect Dis 2009; 48:1003-1032.
37. McMinn P, Carrello A, Cole C, Baker D, Hampson A. Antigenic drift of influenza A (H3N2) virus in a persistently infected immunocompromised host is similar to that occurring in the community. Clin Infect Dis 1999; 29:456-458.
38. Meschi S, Selleri M, Lalle E et al. Duration of viral shedding in hospitalized patients infected with pandemic H1N1. BMC Infect Dis 2011; 11:140.
39. Schrauwen EJ, Herfst S, Chutinimitkul S et al. Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment. Emerg Infect Dis 2011; 17:200-208.
40. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35(10 Suppl 2):S65-S164.
41. Ontario Agency for Health Protection and Promotion, Provincial Infectious Diseases Advisory Committee. Routine Practices and Additional Precautions in All Health Care Settings. Toronto, ON: Queen's Primer for Ontario, 2011.
42. Casper C, Englund J, Boeckh M. How I treat influenza in patients with hematologic malignancies. Blood 2010; 115:1331-1342.
43. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM. Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep [Practice Guideline]. 2011; 60:1-24.
44. Memoli MJ, Hrabal RJ, Hassantoufighi A, Eichelberger MC, Taubenberger JK. Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts. Clin Infect Dis 2010; 50:1252-1255.